Stock·NASDAQ·Technology
Lumentum Holdings Inc. (LITE)
- Market cap
- $58.77B
- P/E
- n/m
- Dividend yield
- No dividend
- Street target
- $1,168.00median of 26 analysts
- 52-week range
- $215.35 $1,143.00
LITE stock forecast today
Where LITE stands today, and what CleaRank Financial AI makes of it.
LITE at a glance
Lumentum Holdings Inc. (LITE): Hold, 48/100 on CleaRank's AI score.
- Trend Mixed: the price is below both its 50- and 200-day moving averages, though the 50-day is still above the 200-day ($877.17 and $811.60).
- Earnings LITE beat estimates in 8 of its last 8 quarters, yet fell in the first session after 3 of those beats.
- Insiders Insiders sold $157.4M and made no open-market purchases over the last 18 months.
Figures as of November 11, 2026.
CleaRank Financial AI
Lumentum Holdings Inc. (LITE) carries a CleaRank rating of Hold and a model score of 48/100.
Analysts are the strongest support: 20 of 26 rate the stock a buy, and the median target is 80.2% above the price. Valuation is the main drag, since the company has no meaningful P/E after losses and its P/S of 15.70 is 106.6% above the sector median. LITE is in a downtrend, trading 26.12% below its 50-day average of $877.17 and 20.15% below its 200-day average of $811.60. Even so, the price rose 156.69% over the past year.
Only on CleaRank
Figures we compute ourselves from LITE's own price, earnings and insider-filing history. Tap one to see it in context.
LITE stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price below its 50-day average ›
The price of $648.06 is 26.1% below the 50-day simple moving average of $877.17.Price below its 200-day average ›
The price is 20.2% below the 200-day simple moving average of $811.60.50-day average above the 200-day ›
The 50-day average ($877.17) is 8.1% above the 200-day average ($811.60), the arrangement of a rising longer-term trend.In the lower half of its 52-week range ›
The price sits at 47% of its 52-week range, between $215.35 and $1,143.00.
LITE share price
Pick a period: each tab shows how far LITE has moved over it, to the last close.
Today's trading
Where LITE sits inside today's range and its 52-week range.
LITE fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S above the sector median ›
The price-to-sales ratio of 15.70 is 106.6% above the sector median of 7.6.Not profitable over the last 12 months ›
Net income over the last 12 months was -$6.6B on revenue of $3.7B, a net margin of -175.8%.Beat estimates in most recent reports ›
LITE beat the EPS estimate in 8 of its last 8 reports.
Key statistics
The headline figures for LITE.
As of November 11, 2026, LITE trades at $648.06, with a market value of $58.77B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of LITE's valuation, growth and risks.
LITE cannot be valued on a P/E basis, since that measure is not meaningful when earnings per share over the last 12 months are negative. On sales, the price-to-sales ratio of 15.70 is 106.6% above the sector median of 7.6. The company's market capitalisation stands at $58.8B.
LITE is losing money. Its net margin is -175.78%, its operating margin is 27.95%, and its return on equity of -245.79% sits below the sector median of 13.4%. Its debt-to-equity ratio is 0.31.
LITE's most recent quarterly report, released on November 2, 2026, topped expectations: EPS came in at $4.57 against the $4.22 analysts had forecast, a beat of 8.29%. The share price nonetheless slipped 0.62% in the first session after the report.
The record is a clean sweep: 8 beats in 8 reports; even so, 3 of those 8 beats were followed by a lower share price in the first session after the report. The consensus EPS estimate stands at $24.99 for this fiscal year and $39.75 for next.
LITE typically moves 7.50% in a day, and its beta against the S&P 500 is 1.65. While the price remains below its moving averages, the trend is a headwind for anyone holding the shares. The price is 43.30% below the 52-week high of $1,143.00.
LITE against the Technology sector
How LITE compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, LITE trades at 15.70x, +107% versus the sector median of 7.60x.
Return vs XLK: Since Jun 2, 2025, LITE has gained 754.3% against a gain of 49.7% for XLK.
Performance against XLK
LITE and the Technology sector fund over the same days.
Revenue and earnings
How much LITE sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); LITE reported again on November 2, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 83.2% in FY2026 to $3.0B, from $1.6B a year earlier.
Profit margin: The net margin was -230.1% in FY2026, down from 1.6% the year before.
Loss-making: LITE lost $6.9B in FY2026.
Earnings reality check
Did LITE beat what analysts expected, and how did the stock react?
Earnings record: LITE beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Nov 2, 2026after close | $4.22 | $4.57 | +8.29% | -0.62% | -12.89% |
| Aug 11, 2026after close | $2.97 | $3.23 | +8.75% | +13.63% | +6.42% |
| May 5, 2026after close | $2.27 | $2.37 | +4.41% | -5.06% | -0.22% |
| Feb 3, 2026after close | $1.41 | $1.67 | +18.44% | +7.00% | +28.97% |
| Nov 4, 2025after close | $1.03 | $1.10 | +6.80% | +23.57% | +34.04% |
| Aug 12, 2025after close | $0.81 | $0.88 | +8.64% | +0.48% | -1.42% |
| May 6, 2025after close | $0.50 | $0.57 | +14.00% | +2.83% | +15.66% |
| Feb 6, 2025after close | $0.36 | $0.42 | +16.67% | -7.31% | -15.69% |
As of November 11, 2026, LITE has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on November 2, 2026, came in 8.29% above the estimate and the stock moved -0.62% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
LITE AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 40.6, in neutral territory.RSI below 50 ›
An RSI of 40.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of LITE
The score, the reasoning behind it, and what could move the price next.
Lumentum Holdings Inc. (LITE) is trading in a downtrend. The price of $648.06 sits 26.12% below its 50-day average of $877.17 and 20.15% below its 200-day average of $811.60. The 50-day average is 8.08% above the 200-day, so the longer average has not yet caught up with the weaker price. Over the past year, the price is 200.93% above the 52-week low of $215.35, yet 43.30% below the 52-week high of $1,143.00.
A recent pullback sits inside a stronger longer record: the price fell 34.90% over the past month, fell 30.50% over the past three months and rose 156.69% over the past year. The 14-day RSI of 40.6 is in the neutral zone, and the MACD line is negative.
New analyst coverage ›
StoneX started coverage at Buy on October 26, 2026.
Source: Analyst action, StoneX, October 26, 2026
Analyst downgrade ›
B. Riley Securities downgraded it to Neutral from Buy on November 3, 2026.
Source: Analyst action, B. Riley Securities, November 3, 2026
Earnings beat, but the stock fell ›
The November 2, 2026 report beat the EPS estimate by 8.29%, and the share price fell 0.62% in the first session after it.
Source: Earnings report, November 2, 2026
- The two nearest levels to watch are the 20-day EMA at $732.93, which sits above the price, and the 52-week low at $215.35, which sits below it.
- LITE's 14-day RSI is 40.6, which is in the neutral zone, and its MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- The share price slid 0.62% in the first session after the November 2, 2026 report, even though LITE has beaten estimates in 8 of the last 8 reports.
The trend is down because LITE sits below both its 50-day average of $877.17 and its 200-day average of $811.60. A move back above the 200-day would be the first sign of repair. The closest level above the price is the 20-day EMA, at $732.93.
LITE's nearest support sits at the 52-week low of $215.35, the next level below the price. The 14-day RSI reads 40.6, which is in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for LITE, from its daily closes.
As of November 11, 2026, with LITE at $648.06, its 14-day RSI is 40.6 (neutral territory), its 50-day simple moving average is $877.17 and its 200-day is $811.60.
Calculated by CleaRank on daily closes as of November 11, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What LITE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 11, 2026, LITE's 1-year correlation of daily returns is +0.51 with S&P 500 (SPY), +0.59 with Nasdaq 100 (QQQ), +0.14 with Bitcoin (BTC) and +0.09 with gold (XAU).
LITE price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
20 of 26 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $1,168.00 is 80.2% above the price.Buy share not up from three months ago ›
20 of 26 rate it a buy now, against 22 of 26 three months ago.
LITE Wall Street View
12-month price targets
The price, $648.06, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 3, 2026 | B. Riley Securities | Downgrade | Neutral |
| Nov 3, 2026 | TD Cowen | Maintains | Hold |
| Nov 3, 2026 | Susquehanna | Maintains | Positive |
| Nov 3, 2026 | Rosenblatt | Maintains | Buy |
| Nov 3, 2026 | Needham | Maintains | Buy |
| Oct 26, 2026 | StoneX | Initiates | Buy |
As of November 11, 2026, 26 Wall Street analysts cover LITE: 20 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $685.00 to $1,425.00. The median LITE price target is $1,168.00, 80.2% above the price of $648.06.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
LITE risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much LITE tends to move, against the market and on its own.
LITE price history and drawdowns
LITE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Typical daily move of 2% or more ›
A typical daily move is 7.50% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 65.6%, from January 2021 to October 2023, regained by July 2025.Most 1-year holds ended higher ›
63% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since December 2016 ›
$10,000 invested in December 2016 is now worth $171,444, against $40,494 in the S&P 500 (SPY).
LITE Drawdowns & Recovery
As of November 11, 2026, LITE's worst peak-to-trough fall over the last 10 years was -65.6% (January 2021 to October 2023); it regained that peak by July 2025, 21 months after the low, and 63% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into LITE in December 2016 is worth now, against the same amount in the S&P 500.
Against the market: LITE beat the S&P 500 over this period: $171,444 against $40,494.
A $10,000 investment in LITE in December 2016 would be worth about $171,444 today, compared with about $40,494 for the same investment in the S&P 500 benchmark with its dividends reinvested.
Seasonal patterns
Which calendar months have been kind to LITE, and which have not.
Highest average month, February: an average of +11.80%, up in 5 of 10 years, so one or two big years drive that average.
Weakest month, September: an average of -4.10%, up in 2 of 10 years.
This month, November: has averaged +9.19%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Across 10 calendar years of history, LITE's highest average calendar month has been February (average +11.80%, up in 5 of 10 years, so one or two big years drive that average) and its weakest September (average -4.10%, up in 2 of 10 years).
Average return for each calendar month across 10 calendar years of history, from weekly closing prices.
LITE stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in LITE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in LITE today could grow to about $15,455 by 2030 in the base case, with a 90th-percentile outcome near $55,673 and a 10th-percentile outcome around $4,290. Projections are statistical simulations, not guarantees.
LITE Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,002 for LITE by 2030 in the base case, from $648 today (1.5x over 4 years). The 10th-percentile path ends near $278. These are outcomes of a Monte Carlo simulation run on LITE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $381 | $723 | $1,371 | |
| 2028 | $326 | $806 | $1,994 | |
| 2029 | $296 | $898 | $2,725 | |
| 2030 | $278 | $1,002 | $3,608 |
Method: a lognormal simulation of LITE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. LITE is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
LITE insider trading
What the people running the company have bought and sold.
LITE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought LITE shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 11, 2026, LITE insiders reported 61 open-market sales worth $157.4M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Yuen Wupen
Officer
|
Sell | 807 | $764.4K |
| Sep 23, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.4M |
| Sep 15, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.3M |
| Sep 10, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.4M |
| Sep 4, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.3M |
| Sep 1, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.4M |
| Aug 27, 2026 | Michael E. Hurlston
Chief Executive Officer
|
Sell | 548 | $525.3K |
| Aug 27, 2026 | Yuen Wupen
Officer
|
Sell | 500 | $479.3K |
| Aug 26, 2026 | Yuen Wupen
Officer
|
Sell | 1.5K | $1.3M |
| Aug 25, 2026 | Vincent D Retort
Officer
|
Sell | 38.7K | $33.0M |
| Aug 25, 2026 | Jae Kim
General Counsel
|
Sell | 12.0K | $10.2M |
| Aug 25, 2026 | Wajid Ali
Chief Financial Officer
|
Grant | 5.0K | - |
| Aug 25, 2026 | Eric Chang
Officer
|
Grant | 900 | - |
| Aug 25, 2026 | Michael E. Hurlston
Chief Executive Officer
|
Grant | 7.9K | - |
| Aug 25, 2026 | Jae Kim
General Counsel
|
Grant | 1.6K | - |
| Aug 25, 2026 | Yuen Wupen
Officer
|
Grant | 5.1K | - |
| Aug 21, 2026 | Yuen Wupen
Officer
|
Sell | 2.0K | $1.7M |
| Aug 20, 2026 | Vincent D Retort
Officer
|
Sell | 2.5K | $2.1M |
| Aug 20, 2026 | Jae Kim
General Counsel
|
Sell | 1.9K | $1.6M |
| Aug 18, 2026 | Vincent D Retort
Officer
|
Sell | 3.2K | $2.9M |
| Aug 18, 2026 | Jae Kim
General Counsel
|
Sell | 1.4K | $1.2M |
| Aug 17, 2026 | Wajid Ali
Chief Financial Officer
|
Grant | 53.3K | - |
| Aug 17, 2026 | Wajid Ali
Chief Financial Officer
|
Grant | 22.8K | - |
| Aug 17, 2026 | Michael E. Hurlston
Chief Executive Officer
|
Grant | 66.8K | - |
| Aug 17, 2026 | Jae Kim
General Counsel
|
Grant | 33.4K | - |
| Aug 17, 2026 | Jae Kim
Chief Financial Officer
|
Grant | 11.6K | - |
| Aug 17, 2026 | Vincent D Retort
Officer
|
Grant | 15.2K | - |
| Aug 17, 2026 | Vincent D Retort
Officer
|
Grant | 64.0K | - |
| Aug 17, 2026 | Yuen Wupen
Officer
|
Grant | 22.8K | - |
| Aug 17, 2026 | Yuen Wupen
Officer
|
Grant | 57.1K | - |
| Jul 15, 2026 | Pamela Fletcher
Director
|
Grant | 108 | - |
| Jul 15, 2026 | Penelope A Herscher
Director
|
Grant | 108 | - |
| Jul 15, 2026 | Julia Suzanne Johnson
Director
|
Grant | 108 | - |
| Jul 15, 2026 | Brian J Lillie
Director
|
Grant | 108 | - |
| Jul 15, 2026 | Ian Seymour Small
Director
|
Grant | 108 | - |
| Jul 15, 2026 | Trent Thad
Director
|
Grant | 108 | - |
| Jun 2, 2026 | Isaac Hosojiro Harris
Director
|
Sell | 1.4K | $1.4M |
| May 29, 2026 | Isaac Hosojiro Harris
Director
|
Sell | 4.0K | $3.4M |
| May 29, 2026 | Isaac Hosojiro Harris
Director
|
Grant | 952 | - |
| May 21, 2026 | Ian Seymour Small
Director
|
Sell | 5.0K | $4.3M |
| May 18, 2026 | Yuen Wupen
Officer
|
Sell | 3.2K | $3.1M |
| May 18, 2026 | Vincent D Retort
Officer
|
Sell | 3.2K | $3.0M |
| May 18, 2026 | Wajid Ali
Chief Financial Officer
|
Sell | 2.5K | $2.4M |
| May 18, 2026 | Jae Kim
General Counsel
|
Sell | 1.4K | $1.4M |
| May 15, 2026 | Pamela Fletcher
Director
|
Sell | 3.2K | $3.1M |
| May 11, 2026 | Brian J Lillie
Director
|
Sell | 12.0K | $11.7M |
| May 11, 2026 | Jae Kim
General Counsel
|
Sell | 1.9K | $1.8M |
| May 11, 2026 | Brian J Lillie
Director
|
Sell | 49 | $49.2K |
| May 8, 2026 | Ian Seymour Small
Director
|
Sell | 3.5K | $3.2M |
| Feb 27, 2026 | Wajid Ali
Chief Financial Officer
|
Sell | 5.3K | $3.7M |
| Feb 27, 2026 | Isaac Hosojiro Harris
Officer and Director
|
Grant | 611 | - |
| Feb 17, 2026 | Vincent D Retort
Officer
|
Sell | 3.4K | $1.9M |
| Feb 13, 2026 | Eric Chang
Officer
|
Grant | 5.0K | - |
| Feb 12, 2026 | Vincent D Retort
Officer
|
Sell | 45.0K | $26.6M |
| Feb 12, 2026 | Penelope A Herscher
Director
|
Sell | 4.0K | $2.4M |
| Feb 6, 2026 | Penelope A Herscher
Director
|
Sell | 4.8K | $2.6M |
| Jan 30, 2026 | Isaac Hosojiro Harris
Officer and Director
|
Grant | 629 | - |
| Dec 31, 2025 | Isaac Hosojiro Harris
Officer and Director
|
Grant | 870 | - |
| Dec 29, 2025 | Trent Thad
Director
|
Grant | 1.2K | - |
| Nov 19, 2025 | Pamela Fletcher
Director
|
Sell | 3.4K | $935.8K |
| Nov 19, 2025 | Yuen Wupen
Officer
|
Sell | 822 | $212.9K |
| Nov 19, 2025 | Pamela Fletcher
Director
|
Grant | 4.1K | - |
| Nov 19, 2025 | Isaac Hosojiro Harris
Director
|
Grant | 1.3K | - |
| Nov 19, 2025 | Penelope A Herscher
Director
|
Grant | 1.3K | - |
| Nov 19, 2025 | Julia Suzanne Johnson
Director
|
Grant | 1.3K | - |
| Nov 19, 2025 | Brian J Lillie
Director
|
Grant | 1.3K | - |
| Nov 19, 2025 | Paul R. Lundstrom
Director
|
Grant | 3.7K | - |
| Nov 19, 2025 | Ian Seymour Small
Director
|
Grant | 1.3K | - |
| Nov 18, 2025 | Yuen Wupen
Officer
|
Sell | 1.6K | $394.2K |
| Nov 18, 2025 | Jae Kim
General Counsel
|
Sell | 1.5K | $361.9K |
| Nov 17, 2025 | Pamela Fletcher
Director
|
Sell | 579 | $144.8K |
| Nov 10, 2025 | Julia Suzanne Johnson
Director
|
Sell | 10.0K | $2.7M |
| Nov 7, 2025 | Isaac Hosojiro Harris
Director
|
Sell | 7.2K | $1.8M |
| Nov 7, 2025 | Matthew Joseph Sepe
Officer
|
Sell | 4.2K | $1.0M |
| Aug 27, 2025 | Yuen Wupen
Officer
|
Sell | 6.6K | $817.9K |
| Aug 26, 2025 | Wajid Ali
Chief Financial Officer
|
Sell | 2.5K | $314.2K |
| Aug 25, 2025 | Yuen Wupen
Officer
|
Sell | 3.3K | $391.4K |
| Aug 22, 2025 | Jae Kim
General Counsel
|
Sell | 4.5K | $526.8K |
| Aug 22, 2025 | Wajid Ali
Chief Financial Officer
|
Grant | 12.3K | - |
| Aug 22, 2025 | Jae Kim
General Counsel
|
Grant | 7.7K | - |
| Aug 22, 2025 | Matthew Joseph Sepe
Officer
|
Grant | 4.9K | - |
| Aug 22, 2025 | Yuen Wupen
Officer
|
Grant | 13.2K | - |
| Aug 21, 2025 | Wajid Ali
Chief Financial Officer
|
Grant | 31.9K | - |
| Aug 21, 2025 | Jae Kim
General Counsel
|
Grant | 13.7K | - |
| Aug 21, 2025 | Vincent Retort
Officer
|
Grant | 25.3K | - |
| Aug 21, 2025 | Matthew Joseph Sepe
Officer
|
Grant | 9.6K | - |
| Aug 21, 2025 | Yuen Wupen
Officer
|
Grant | 32.0K | - |
| Aug 19, 2025 | Yuen Wupen
Officer
|
Sell | 327 | $37.9K |
| Aug 19, 2025 | Michael E. Hurlston
Chief Executive Officer
|
Grant | 34.4K | - |
| Aug 18, 2025 | Wajid Ali
Chief Financial Officer
|
Sell | 2.2K | $258.8K |
| Aug 18, 2025 | Julia Suzanne Johnson
Director
|
Sell | 1.3K | $148.8K |
| Aug 18, 2025 | Jae Kim
General Counsel
|
Sell | 912 | $106.2K |
| Aug 7, 2025 | Wajid Ali
Chief Financial Officer
|
Grant | 5.1K | - |
| Aug 7, 2025 | Vincent Retort
Officer
|
Grant | 6.2K | - |
| Aug 7, 2025 | Matthew Joseph Sepe
Officer
|
Grant | 1.3K | - |
| Aug 7, 2025 | Yuen Wupen
Officer
|
Grant | 1.5K | - |
| Aug 6, 2025 | Yuen Wupen
Officer
|
Sell | 241 | $26.1K |
| Aug 5, 2025 | Yuen Wupen
Officer
|
Sell | 482 | $53.0K |
| Jul 29, 2025 | Vincent Retort
Officer
|
Sell | 22.7K | $2.5M |
| Jul 23, 2025 | Yuen Wupen
Officer
|
Sell | 265 | $26.5K |
| Jul 22, 2025 | Yuen Wupen
Officer
|
Sell | 528 | $54.2K |
| Jun 26, 2025 | Alan S Lowe
Director
|
Sell | 20.0K | $1.9M |
| Jun 18, 2025 | Alan S Lowe
Director
|
Sell | 20.0K | $1.8M |
| Jun 4, 2025 | Alan S Lowe
Director
|
Sell | 10.0K | $835.8K |
| Jun 4, 2025 | Wajid Ali
Chief Financial Officer
|
Sell | 2.2K | $185.7K |
| May 19, 2025 | Yuen Wupen
President
|
Sell | 579 | $44.5K |
| May 16, 2025 | Jae Kim
General Counsel
|
Sell | 4.6K | $356.9K |
| May 15, 2025 | Yuen Wupen
Officer
|
Sell | 13.6K | $1.0M |
Source: TwelveData, from SEC Form 4 filings
LITE stock forecast: questions people ask
Answered from the figures on this page, as of November 11, 2026.